Perrigo reported $0.77 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.33 0.60 May/12 2026
FY2025Q4 Dec/2025 0.77 0.79 0.36 Feb/26 2026
FY2025Q3 Sep/2025 0.80 0.76 0.81 Nov/05 2025
FY2025Q2 Jun/2025 0.57 0.59 0.53 Aug/06 2025
FY2025Q1 Mar/2025 0.60 0.48 0.29 May/07 2025




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Abbott USD 1.5 0.2 Dec/2025
Bayer EUR 0.62 0.05 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Coherus Biosciences USD -0.35 0.07 Mar/2025
Corcept Therapeutics USD 0.2 0.04 Dec/2025
Dr.Reddys Laboratories INR 14.52 2.98 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
J&J USD 2.46 0.34 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Nestle CHF 2.09 0.15 Jun/2025
Pacira USD 0.06 0.64 Dec/2025
Perrigo USD 0.77 0.03 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 1.14 0.07 Dec/2025
Reckitt Benckiser GBP 1.84 0.43 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
Supernus Pharmaceuticals USD -0.07 0.73 Dec/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025
Xeris Pharmaceuticals USD 0 0.02 Sep/2025
Zoetis USD 1.48 0.22 Dec/2025